Medical Oncologist
Before your procedure
Surgery and Dental Procedures on Ibrutinib: — The Bleeding Rule
Ibrutinib changes the way your platelets behave, which makes uncontrolled bleeding during or after surgery a real risk. Before any planned procedure, your surgical team and your oncologist need to agree on the hold window — how many days to stop ibrutinib, and when it is safe to restart.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Stop before you go under — Ibrutinib affects platelet function in a way that increases bleeding risk. It needs to be held before any elective procedure.
- Three to seven days is the window — The prescribing information specifies at least three to seven days before surgery, depending on the procedure's bleeding risk.
- Restart is not immediate — You also need to wait at least three to seven days after surgery, once bleeding has settled, before resuming ibrutinib.
- Both teams need to talk — Your oncologist and your surgeon should agree on the plan together. Neither should make this decision without the other.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
If you take ibrutinib and need any surgery or invasive dental work, the prescribing information recommends stopping it at least three to seven days beforehand. You also need to wait at least three to seven days after the procedure before restarting, once bleeding has been confirmed to have stopped. Your surgeon and oncologist must plan this together.
Why does ibrutinib make bleeding a concern during surgery?
Ibrutinib works by blocking a protein called BTK, which is active in certain cancer cells. BTK is also involved in how platelets clump together to form a clot when you bleed.
By blocking BTK, ibrutinib reduces the ability of platelets to stick together. This does not always cause obvious bleeding in daily life, but it becomes significant when tissue is cut during surgery.
This is not the same as having a low platelet count, and it is not corrected by vitamin K or other standard clot-supporting measures. It is a functional change in how your platelets behave, which is why simply knowing your platelet count is not enough for your surgical team to assess the risk.
How many days before surgery should you stop ibrutinib?
The ibrutinib prescribing information recommends holding the drug for at least three to seven days before and after any elective surgery. The exact number of days within that range depends on the type of surgery and how high the bleeding risk is.
A minor procedure with low bleeding risk may require only three days. A major operation involving large blood vessels or organs typically warrants the longer end of the window.
Your oncologist and surgeon decide the number of days together, based on your specific procedure. Do not adjust the timing yourself without that conversation.
Does the same rule apply to dental procedures?
Yes, for any invasive dental work — extractions, implants, biopsies, or deep cleaning that breaks gum tissue. The prescribing guidance does not distinguish between surgical and dental procedures.
Routine non-invasive check-ups do not require a hold period. If you are unsure whether your appointment counts as invasive, tell your dentist you are on ibrutinib before any instruments touch your gums.
For emergency surgery where waiting is not possible, tell the surgical team you are on ibrutinib immediately. They can plan for additional haemostatic support during the procedure — but only if they know.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
Terms your team may use when planning this
- Hold period
- The days when ibrutinib is paused around a procedure. A planned safety measure, not a break in your overall treatment.
- Haemostasis
- The process by which bleeding stops after tissue is cut. Ibrutinib slows the platelet step of this process.
- BTK inhibitor
- The class of drug ibrutinib belongs to. BTK is a protein active in cancer cells and in platelet function.
- Elective procedure
- A planned procedure that can be scheduled in advance. Most surgical and dental procedures are elective, which is why the hold period is usually possible to arrange.
- Bridging therapy
- Using another medication temporarily while ibrutinib is held. Rarely needed for ibrutinib specifically, but your team may raise it depending on your situation.
Did you know?
The increased bleeding risk from ibrutinib works through a different mechanism than blood thinners such as warfarin or aspirin. Reversing warfarin with vitamin K does not correct the platelet-function change that ibrutinib causes.
This is why your surgical team needs to know you are on ibrutinib specifically — standard blood-thinner protocols do not cover it.
Source: Ibrutinib (Imbruvica) prescribing information; NCCN Guidelines: B-Cell Lymphomas
Questions families ask most about holding ibrutinib for surgery
What if my surgery cannot wait and I have not stopped ibrutinib?
Tell the surgical team immediately that you are on ibrutinib and when you last took it. Emergency surgical teams can plan additional measures to manage bleeding intraoperatively — but only if they know. Do not assume this information is already on your file. Say it directly to the surgeon and the anaesthetist before you go in.
Will stopping ibrutinib for a week allow my cancer to progress?
A hold of three to seven days around a procedure is not expected to affect the long-term control of your disease. Ibrutinib is a continuous therapy and a short planned interruption is built into the prescribing guidance for exactly this reason. Your oncologist can reassure you about your specific situation and what monitoring they recommend during and after the hold.
Who coordinates the hold — my oncologist or my surgeon?
Both teams share responsibility, but the oncologist typically leads the decision on hold duration and when restarting is safe. Make sure both are in contact before your procedure date is confirmed. If you are arranging surgery at a different hospital from where you receive ibrutinib, take a letter from your oncologist that states your medication and the agreed hold plan.
Do I need to hold ibrutinib for a gastroscopy or colonoscopy?
Endoscopic procedures that involve biopsies or polypectomy carry a bleeding risk and are generally treated the same way as surgery in terms of the hold period. A diagnostic endoscopy with no tissue removal is lower risk, but this should still be discussed with your oncologist before the appointment. Do not assume a camera test is safe without checking first.
Can I take ibuprofen or aspirin for pain around the time of surgery?
Anti-inflammatory painkillers such as ibuprofen, diclofenac and aspirin also affect platelet function and add to the bleeding risk from ibrutinib. The prescribing information advises caution with any medicine that affects platelet function while on ibrutinib. Paracetamol is generally the safer choice for pain after a procedure. Confirm with your oncologist before taking anything new around the time of surgery.
When exactly can I restart ibrutinib after surgery?
The prescribing information states at least three to seven days after surgery, once haemostasis has been established — meaning the surgical team is satisfied that bleeding has stopped and the wound is stable. Your oncologist makes the final call, usually after speaking with the surgeon. Do not restart on your own initiative without that confirmation, even if you feel well.
Explore 75 more Blood Cancer Targeted Medicines topics
Drug Deep Dive: Ibrutinib (Imbruvica)
- Diarrhoea, Joint Pain and Infection Risk on Ibrutinib
- Diet and Nutrition While on Ibrutinib
- Easy Bruising and Bleeding on Ibrutinib: What Is Normal and What Is Not
- Fertility, Pregnancy and Contraception on Ibrutinib
- How Does Ibrutinib Work? The BTK Inhibitor Explained
- How Long Does Ibrutinib Take to Work?
- How Long Will You Stay on Ibrutinib?
- Ibrutinib (Imbruvica, Ibrutix): The Complete Patient Guide
- Ibrutinib Interactions: Blood Thinners, Antifungals and Fish Oil
- Ibrutinib Myths: Lifelong Treatment, Bruising and 'It's Not Real Treatment'
- Ibrutinib Price in India: Brand, Generic and Monthly Cost
- Ibrutinib Side Effects: The Complete List and Timeline
- Ibrutinib Success Rate and Survival: An Honest Look at the Numbers
- Ibrutinib With Rituximab or Venetoclax: Continuous vs Fixed-Duration Therapy
- Ibrutinib in CLL, Mantle Cell Lymphoma and Waldenstrom's
- Ibrutinib in Elderly Patients and Those With Other Illnesses
- Ibrutinib vs Acalabrutinib vs Zanubrutinib: Comparing BTK Inhibitors
- Palpitations, Atrial Fibrillation and High Blood Pressure on Ibrutinib
- Surgery and Dental Procedures on Ibrutinib: The Bleeding Rule
- Taking Ibrutinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Ibrutinib
- When Ibrutinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Ibrutinib? CLL, Mantle Cell Lymphoma and Waldenstrom's Macroglobulinaemia
- Will Insurance or a Government Scheme Pay for Ibrutinib?
- Work, Travel and Daily Life on Ibrutinib
Drug Deep Dive: Imatinib (Gleevec)
- Adjuvant Imatinib After GIST Surgery: How Many Years?
- BCR-ABL PCR Monitoring: What 'Log Reduction' and 'MR4.5' Mean
- Can You Ever Stop Imatinib? Treatment-Free Remission Explained
- Diet and Nutrition While on Imatinib
- Fertility, Pregnancy and Contraception on Imatinib
- How Does Imatinib Work? The BCR-ABL and KIT Inhibitor Explained
- How Long Does Imatinib Take to Work?
- Imatinib (Gleevec, Veenat, Imatib): The Complete Patient Guide
- Imatinib Interactions: Paracetamol, Antacids and Herbal Medicines
- Imatinib Myths: Lifelong Dependence, Fertility and Generic Quality
- Imatinib Price in India: Brand, Generic and Monthly Cost
- Imatinib Side Effects: The Complete List and Timeline
- Imatinib Success Rate and Survival: An Honest Look at the Numbers
- Imatinib for GIST: How It Differs From CML Treatment
- Imatinib in Elderly Patients and Those With Other Illnesses
- Imatinib vs Nilotinib vs Dasatinib: Choosing a CML Drug
- Muscle Cramps and Bone Pain on Imatinib: What Actually Helps
- Nausea, Stomach Upset and Weight Gain on Imatinib
- Puffy Eyes and Swollen Legs on Imatinib: Managing Fluid Retention
- Taking Imatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Imatinib
- When Imatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Imatinib? Chronic Myeloid Leukaemia and GIST
- Will Insurance or a Government Scheme Pay for Imatinib?
- Work, Travel and Daily Life on Imatinib
Drug Deep Dive: Rituximab (MabThera)
- Diet and Nutrition While on Rituximab
- Drug, Food and Supplement Interactions With Rituximab
- Fertility, Pregnancy and Contraception on Rituximab
- Hepatitis B Reactivation and Rituximab: The Test You Must Not Skip
- How Does Rituximab Work? The Anti-CD20 Monoclonal Antibody Explained
- How Long Does Rituximab Take to Work?
- How Long Will You Stay on Rituximab?
- Low Antibodies and Repeated Infections After Rituximab
- MabThera vs Biosimilar Rituximab in India: Cost and Equivalence
- R-CHOP and Other Rituximab Combinations Explained
- Rituximab (MabThera, Ristova and biosimilars): The Complete Patient Guide
- Rituximab Infusion Day: Premedication, Duration and What to Expect
- Rituximab Infusion Reactions: Why the First Infusion Is Different
- Rituximab Maintenance: Two More Years of Infusions, and Why
- Rituximab Myths: Vaccines, Immunity and 'Permanent Damage'
- Rituximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Rituximab Side Effects: The Complete List and Timeline
- Rituximab Success Rate and Survival: An Honest Look at the Numbers
- Rituximab in Elderly Patients and Those With Other Illnesses
- Tests and Monitoring While You Are on Rituximab
- When Rituximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Rituximab? B-Cell Lymphoma and CLL
- Why the Same Drug Treats Arthritis and Lymphoma
- Will Insurance or a Government Scheme Pay for Rituximab?
- Work, Travel and Daily Life on Rituximab
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Do I need to stop ibrutinib for a blood test or an IV cannula?
No. Minor, non-invasive procedures such as a blood draw or an IV cannula do not require a hold period. The prescribing guidance applies to surgery and other procedures where tissue is cut and significant bleeding is possible. If you are ever unsure whether a planned procedure falls into this category, ask your oncology nurse before the appointment.
Is the bleeding risk mainly because ibrutinib lowers my platelet count?
Not usually. The primary bleeding risk from ibrutinib is functional — it changes how platelets behave rather than reducing their number. Your platelet count may be within a normal range while this functional change is still present. This is why disclosing your ibrutinib use to your surgical team specifically matters, rather than assuming a normal blood count tells them everything they need to know.
What should I tell my dentist before booking an invasive dental procedure?
Tell them you are on ibrutinib before any treatment is planned — not on the day. Your dentist needs to contact your oncologist to confirm the hold period and get clearance before carrying out any extraction, implant, biopsy or procedure that breaks gum tissue. Bring the name and contact details of your oncology team to the appointment, and do not let any invasive dental work proceed without this coordination in place.
Will I need extra blood tests or monitoring during the hold period?
Your oncologist will advise on this based on your disease and how stable your condition has been. For a short planned hold around an elective procedure, additional testing is not always required. If your disease is being closely monitored, your oncologist may want to bring a check forward so that results are available before surgery. Ask when the hold is planned rather than waiting to be told.
Can I take my other regular medicines during the ibrutinib hold?
Generally yes, but confirm with your oncologist for any medicine that also affects bleeding. This includes aspirin even at low doses, other anti-inflammatory drugs, fish oil, and certain supplements such as ginkgo. The hold is specific to ibrutinib unless your team tells you otherwise. Bring a complete list of everything you take — including supplements — to your pre-operative assessment.
How do I make sure my surgical team knows I am on ibrutinib?
Mention it at every pre-operative contact — when the procedure is booked, at the pre-operative assessment, and again on the day. Do not assume it has been transferred from your oncology records. Write the name ibrutinib — also sold as Imbruvica — on any medication form you are asked to fill in. If the surgical team seems unfamiliar with it, ask them to contact your oncologist directly before proceeding.